摘要:
A method for treating cardiovascular disease in a mammalian subject includes providing to the subject at least one treatment regimen including at least one estrogen receptor modulator, wherein the at least one treatment regimen is determined based on the APOE allelic profile in the subject, and based on the steroid hormone levels prior to disease diagnosis and on current steroid hormone levels in the subject.
摘要:
A method, device, or kit is provided which maintain a substantially physiological level of one or more steroid hormones in a mammalian subject in need thereof. The method, device, or kit includes providing to the subject at least one treatment regimen including replacement therapy for the one or more steroid hormones or metabolites or modulators thereof, wherein the at least one treatment regimen is determined based on steroid hormone levels prior to disease diagnosis in the subject and on current steroid hormone levels in the subject, wherein the at least one treatment regimen is configured to maintain the subject's one or more steroid hormones or metabolites or modulators thereof at substantially physiological pre-disease levels. The method, device, or kit can be used for the treatment of a disease or condition in the mammalian subject.
摘要:
A method, device, or kit is provided which maintain a substantially physiological cyclic pre-menopausal level of one or more steroid hormones in a mammalian subject in need thereof. The method, device, or kit includes providing to the subject at least one treatment regimen including replacement therapy for the one or more steroid hormones or metabolites or modulators thereof, wherein the at least one treatment regimen is determined based on pre-menopausal cyclic steroid hormone levels of the subject and on current cyclic steroid hormone levels of the subject, wherein the at least one treatment regimen is configured to maintain the subject's one or more steroid hormones or metabolites or modulators thereof at substantially physiological cyclic pre-menopausal levels. The method, device, or kit can be used for the treatment of a disease or condition in the mammalian subject.
摘要:
Methods, computer program products, and systems are described that include accepting at least one indication of bioactive agent use by an individual and/or presenting an indication of an artificial sensory experience programmed to detect at least one effect of the bioactive agent at least partly based on the at least one indication of the bioactive agent.
摘要:
Methods, computer program products, and systems are described that include detecting at least one indication of bioactive agent use by an individual and/or altering an artificial sensory experience to modify at least one effect of the bioactive agent.
摘要:
Described embodiments include a system, method, and computer program product. A described system includes a receiver circuit that receives a first reference image that includes an objective landmark subsurface feature of a mammalian body part, and receives a second reference image that includes a present-location landmark subsurface feature of the mammalian body part. The objective landmark subsurface feature has a first spatial relationship to a destination region of interest of the mammalian body part. The present-location landmark subsurface feature has a second spatial relationship to a distal end portion of a body-insertable device. The system includes a feature matching circuit that determines a substantial correspondence between the present-location landmark subsurface feature and the objective landmark subsurface feature. The system includes a proximity indicator circuit that generates informational data indicative of an operational proximity of the distal end portion of the body-insertable device to the destination region of interest.
摘要:
Described embodiments include a system, method, and computer program product. A described system includes a feature matching circuit that receives a first reference image that includes a representation of a distinctive landmark subsurface feature of a body part of a known patient and a second reference image that includes a representation of a contemporaneously acquired landmark subsurface feature of a body part of a person presenting. A feature matching circuit determines a correspondence between the distinctive landmark subsurface feature of a body part of a known patient and the contemporaneously-acquired landmark subsurface feature of a body part of a person presenting. A data circuit generates informational data indicative of a verification of the person presenting with respect to the known patient, the verification at least partially based on the determined correspondence between the distinctive landmark subsurface feature and the contemporaneously-acquired landmark subsurface feature. A communication circuit outputs the informational data.
摘要:
Configuration technologies for cost-effectively monitoring indicia of regimen compliance or noncompliance in response to one or more indications of symptoms or actions or other data on data-bearing media or in wireless transmissions, such as implementing techniques for providing or preventing access or otherwise acting on or communicating incremental or definitive indicia of compliance or noncompliance.
摘要:
Configuration technologies for cost-effectively monitoring indicia of regimen compliance or noncompliance in response to one or more indications of symptoms or actions or other data on data-bearing media or in wireless transmissions, such as implementing techniques for providing or preventing access or otherwise acting on or communicating incremental or definitive indicia of compliance or noncompliance.
摘要:
Systems, devices, and methods are described for registering treatment focal regions with adipose depot targets and for transcutaneously delivering an energy stimulus to the treatment focal regions when treatment registration information indicates that the treatment focal regions coincide with the anatomical targets.